Biotech Integrated Solutions From Pall's Process Engineering & Project Management Team

Scaling gene therapy, mAb, or vaccine therapeutic drug products from bench to manufacturing involves a balancing act between project management, risk mitigation, and process parameter selection. A holistically-executed development that takes these into consideration can help identify and mitigate risks before they occur and protect the project budget – ultimately accelerating speed to market.

Join Pall for this webinar as they explore the ways to apply best practices through implementation of the Biotech Integrated Solutions service architecture for large-scale manufacturing projects, ultimately accelerating speed to market.